Ohio Public Employees Retirement System (OPERS)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
GCL
HI
Ohio Public Employees Retirement System (OPERS)'s CPRX Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) increased its Catalyst Pharmaceutical (CPRX) stake by 93% in Q2 2026, buying an estimated $4.4K and bringing the position to 309 shares worth $9.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.
Ohio Public Employees Retirement System (OPERS) first reported a position in CPRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $735K in Q1 2022. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 309 shares of Catalyst Pharmaceutical worth $9.71K as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) bought 149 Catalyst Pharmaceutical shares in Q2 2026, an estimated $4.4K.
- Catalyst Pharmaceutical made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #2266 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 5 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Catalyst Pharmaceutical position peaked at $735K in Q1 2022.
- 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.